Rezultati pretraživanja
  1. prije 2 sata

    Since the outbreak of has spread globally, have been quick to invest in company – (: ), which has seen an major spike in trading volume, increasing its share price 75%.

  2. prije 11 sati

    5th Feb 2020: Center for BioPharma Analysis team attending workshop, Hands on training at ICT, Mumbai. National Biopharma Mission sponsored Hands-on Programme for Product Development.

  3. BioProcess International’s editors share their experiences of the 2019 BPI US conference in Boston, focusing attention on elements that are driving in the industry

  4. prije 13 sati

    AAMI and , two nonprofit associations with similar missions and professional members in the , , and industries, have announced an agreement to explore ways to collaborate.

  5. prije 13 sati

    Go Behind the Scenes at Teva’s state-of-the-art facility in Ulm, Germany, and meet the experts who are advancing more treatment options for patients

  6. We are a forward-thinking, mid-sized contract research organization, offering companies of all sizes a proven, flexible approach to early , from lead candidate selection to proof of concept

  7. prije 16 sati

    Need to train/retrain your team(s) in manufacturing & their respective equipment pieces? Look no further! Our suite of modules is suitable for all levels of experience:

  8. 4. velj

    To achieve characterization of a , knowledge of the applied analytical IEF procedure can be done by applying a Design of Experiments approach. See how Institute of Medicinal and Pharmaceutical Chemistry researchers use icIEF on Maurice.

  9. 4. velj

    Important news today. Tetra announced that FDA guidance allows expansion into a larger therapeutics market for and avoids direct competition with . . Read more here

  10. 4. velj
  11. 4. velj

    Based on the FDA decisions, guidance, Tetra confirms that CAUMZ will be able to benefit from three regulatory programs which will lower overall costs. cancer and pain. . For the full story

  12. 3. velj

    Tetra meets FDA conditions for Fast Track designation for patients with advanced, incurable that’s uncontrolled by standard treatments. . Read more here

  13. 3. velj

    UK-based company, PhoreMost, and Boehringer Ingelheim, a world-leading company, have entered into a multi-project . Find out more, here:

  14. 3. velj

    This week's MTIG Member Company Series is dedicated to . Takeda is a patient-focused, values-based, R&D-driven global company committed to bringing better and a brighter future to people worldwide. Learn more:

  15. 1. velj

    The adoption of Industry 4.0 manufacturing principles can enable companies to deliver novel therapies amid a changing disease landscape. Learn more here 👉

  16. 31. sij

    | Enterprise Middleware Platform | A leading company curbed compliance risk through a upgraded ent-wide platform. Learn the services that led the company to realize cost savings and eliminate technical debt:

  17. 31. sij

    is a clinical stage company with the scientific vision of revolutionizing the treatment of by redirecting the body’s potent anti-viral immune response to recognize and kill cancer cells.

  18. 30. sij

    Another excellent day at 's ! Talk to us about your and , Medical Device talent and support needs at stand B605!

  19. 29. sij
  20. 29. sij

    and Cloud team up on the INTIENT Platform to help the world’s leading companies advance the discovery, development and delivery of innovative therapies.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.